- Home
- HEPA vs SXTC Comparison
HEPA vs SXTC Comparison
Compare HEPA & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- SXTC
- Stock Information
- Founded
- HEPA 2013
- SXTC 2005
- Country
- HEPA United States
- SXTC China
- Employees
- HEPA N/A
- SXTC N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- HEPA Health Care
- SXTC Health Care
- Exchange
- HEPA Nasdaq
- SXTC Nasdaq
- Market Cap
- HEPA 1.7M
- SXTC 1.6M
- IPO Year
- HEPA N/A
- SXTC 2019
- Fundamental
- Price
- HEPA $0.17
- SXTC $0.34
- Analyst Decision
- HEPA
- SXTC
- Analyst Count
- HEPA 0
- SXTC 0
- Target Price
- HEPA N/A
- SXTC N/A
- AVG Volume (30 Days)
- HEPA 31.4M
- SXTC 315.4K
- Earning Date
- HEPA 04-15-2025
- SXTC 08-19-2019
- Dividend Yield
- HEPA N/A
- SXTC N/A
- EPS Growth
- HEPA N/A
- SXTC N/A
- EPS
- HEPA N/A
- SXTC N/A
- Revenue
- HEPA N/A
- SXTC $1,928,497.00
- Revenue This Year
- HEPA N/A
- SXTC N/A
- Revenue Next Year
- HEPA N/A
- SXTC N/A
- P/E Ratio
- HEPA N/A
- SXTC N/A
- Revenue Growth
- HEPA N/A
- SXTC N/A
- 52 Week Low
- HEPA $0.12
- SXTC $0.30
- 52 Week High
- HEPA $3.33
- SXTC $3.37
- Technical
- Relative Strength Index (RSI)
- HEPA 36.41
- SXTC 33.64
- Support Level
- HEPA $0.17
- SXTC $0.37
- Resistance Level
- HEPA $0.19
- SXTC $0.40
- Average True Range (ATR)
- HEPA 0.02
- SXTC 0.03
- MACD
- HEPA 0.01
- SXTC -0.00
- Stochastic Oscillator
- HEPA 28.55
- SXTC 2.22
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.